Arg13 of B-type natriuretic peptide reciprocally modulates binding to guanylyl cyclase but not clearance receptors

Molecular Pharmacology

Volumn 78, Issue 3, 2010, Pages 431-435

  Dickey, Deborah M ^a   Barbieri, Kathryn A ^a   McGuirk, Christopher M ^a   Potter, Lincoln R ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARGININE; BRAIN NATRIURETIC PEPTIDE; GLYCINE; LEUCINE; METHIONINE; NATRIURETIC PEPTIDE RECEPTOR A; NATRIURETIC PEPTIDE RECEPTOR B; NATRIURETIC PEPTIDE RECEPTOR C; SERINE; ATRIAL NATRIURETIC FACTOR RECEPTOR; GUANYLATE CYCLASE; NATRIURETIC FACTOR; PEPTIDE; RECEPTOR;

AMINO ACID SUBSTITUTION; ARTICLE; CELL STIMULATION; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME BINDING; HUMAN; HUMAN CELL; PRIORITY JOURNAL; RECEPTOR AFFINITY; DOWN REGULATION; GENETICS; HEART FAILURE; HYPERTENSION; HYPERTROPHY; KIDNEY; METABOLISM; PHYSIOLOGY;

DOWN-REGULATION; GUANYLATE CYCLASE; HEART FAILURE; HUMANS; HYPERTENSION; HYPERTROPHY; KIDNEY; NATRIURETIC PEPTIDE, BRAIN; NATRIURETIC PEPTIDES; PEPTIDES; RECEPTORS, ATRIAL NATRIURETIC FACTOR; RECEPTORS, PEPTIDE;

EID: 77956245721     PISSN: 0026895X     EISSN: 15210111     Source Type: Journal    
DOI: 10.1124/mol.110.066084     Document Type: Article

References (14)

1. Boerrigter G, Costello-Boerrigter LC, and Burnett JC Jr (2009) Natriuretic peptides in the diagnosis and management of chronic heart failure. Heart Fail Clin 5:501-514.
2. Bryan PM, Xu X, Dickey DM, Chen Y, and Potter LR (2007) Renal hyporesponsiveness to atrial natriuretic peptide in congestive heart failure results from reduced atrial natriuretic peptide receptor concentrations. Am J Physiol Renal Physiol 292:F1636-F1644.
3. Dickey DM, Burnett JC Jr, and Potter LR (2008) Novel bifunctional natriuretic peptides as potential therapeutics. J Biol Chem 283:35003-35009.
4. Dickey DM, Flora DR, Bryan PM, Xu X, Chen Y, and Potter LR (2007) Differential regulation of membrane guanylyl cyclases in congestive heart failure: natriuretic peptide receptor (NPR)-B, not NPR-A, is the predominant natriuretic peptide receptor in the failing heart. Endocrinology 148:3518-3522.
5. Dickey DM, Yoder AR, and Potter LR (2009) A familial mutation renders atrial natriuretic peptide resistant to proteolytic degradation. J Biol Chem 284:19196-19202.
6. Furuya M, Tawaragi Y, Minamitake Y, Kitajima Y, Fuchimura K, Tanaka S, Minamino N, Kangawa K, and Matsuo H (1992) Structural requirements of C-type natriuretic peptide for elevation of cyclic GMP in cultured vascular smooth muscle cells. Biochem Biophys Res Commun 183:964-969.
7. Kishimoto I, Dubois SK, and Garbers DL (1996) The heart communicates with the kidney exclusively through the guanylyl cyclase-A receptor: acute handling of sodium and water in response to volume expansion. Proc Natl Acad Sci USA 93:6215-6219.
8. Langenickel TH, Buttgereit J, Pagel-Langenickel I, Lindner M, Monti J, Beuerlein K, Al-Saadi N, Plehm R, Popova E, Tank J, et al. (2006) Cardiac hypertrophy in transgenic rats expressing a dominant-negative mutant of the natriuretic peptide receptor B. Proc Natl Acad Sci USA 103:4735-4740.
9. Lee CY, Chen HH, Lisy O, Swan S, Cannon C, Lieu HD, and Burnett JC Jr (2009) Pharmacodynamics of a novel designer natriuretic peptide, CD-NP, in a first-inhuman clinical trial in healthy subjects. J Clin Pharmacol 49:668-673.
10. Lisy O, Huntley BK, McCormick DJ, Kurlansky PA, and Burnett JC Jr (2008) Design, synthesis, and actions of a novel chimeric natriuretic peptide: CD-NP. J Am Coll Cardiol 52:60-68.
11. Potter LR, Yoder AR, Flora DR, Antos LK, and Dickey DM (2009) Natriuretic peptides: their structures, receptors, physiologic functions and therapeutic applications. Handb Exp Pharmacol 191:341-366.
12. Sackner-Bernstein JD, Skopicki HA, and Aaronson KD (2005) Risk of worsening renal function with nesiritide in patients with acutely decompensated heart failure. Circulation 111:1487-1491.
13. Suga S, Nakao K, Hosoda K, Mukoyama M, Ogawa Y, Shirakami G, Arai H, Saito Y, Kambayashi Y, and Inouye K (1992) Receptor selectivity of natriuretic peptide family, atrial natriuretic peptide, brain natriuretic peptide, and C-type natriuretic peptide. Endocrinology 130:229-239.
14. Wei CM, Aarhus LL, Miller VM, and Burnett JC Jr (1993) Action of C-type natriuretic peptide in isolated canine arteries and veins. Am J Physiol 264:H71-H73.